132 related articles for article (PubMed ID: 26298011)
21. Association of serum estrone levels with estrogen receptor-positive breast cancer risk in postmenopausal Japanese women.
Miyoshi Y; Tanji Y; Taguchi T; Tamaki Y; Noguchi S
Clin Cancer Res; 2003 Jun; 9(6):2229-33. PubMed ID: 12796390
[TBL] [Abstract][Full Text] [Related]
22. [Body mass index and cancer incidence:a prospective cohort study in northern China].
Guo L; Li N; Wang G; Su K; Li F; Yang L; Ren J; Chang S; Chen S; Wu S; He J; Dai M
Zhonghua Liu Xing Bing Xue Za Zhi; 2014 Mar; 35(3):231-6. PubMed ID: 24831616
[TBL] [Abstract][Full Text] [Related]
23. Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women.
Missmer SA; Eliassen AH; Barbieri RL; Hankinson SE
J Natl Cancer Inst; 2004 Dec; 96(24):1856-65. PubMed ID: 15601642
[TBL] [Abstract][Full Text] [Related]
24. Lung cancer risk among female textile workers exposed to endotoxin.
Astrakianakis G; Seixas NS; Ray R; Camp JE; Gao DL; Feng Z; Li W; Wernli KJ; Fitzgibbons ED; Thomas DB; Checkoway H
J Natl Cancer Inst; 2007 Mar; 99(5):357-64. PubMed ID: 17341727
[TBL] [Abstract][Full Text] [Related]
25. Prospective study of leukocyte count as a predictor of incident breast, colorectal, endometrial, and lung cancer and mortality in postmenopausal women.
Margolis KL; Rodabough RJ; Thomson CA; Lopez AM; McTiernan A;
Arch Intern Med; 2007 Sep; 167(17):1837-44. PubMed ID: 17893304
[TBL] [Abstract][Full Text] [Related]
26. Iron status in relation to cancer risk and mortality: Findings from a population-based prospective study.
Quintana Pacheco DA; Sookthai D; Graf ME; Schübel R; Johnson T; Katzke VA; Kaaks R; Kühn T
Int J Cancer; 2018 Aug; 143(3):561-569. PubMed ID: 29574909
[TBL] [Abstract][Full Text] [Related]
27. Pre-diagnostic plasma concentrations of Fibrinogen, sGPIIb/IIIa, sP-selectin, sThrombomodulin, Thrombopoietin in relation to cancer risk: Findings from a large prospective study.
Graf ME; Sookthai D; Johnson T; Schübel R; Maldonado SG; Pletsch-Borba L; Katzke V; Bugert P; Hoffmeister M; Kaaks R; Kühn T
Int J Cancer; 2018 Dec; 143(11):2659-2667. PubMed ID: 29923180
[TBL] [Abstract][Full Text] [Related]
28. A prospective evaluation of plasma phospholipid fatty acids and breast cancer risk in the EPIC study.
Chajès V; Assi N; Biessy C; Ferrari P; Rinaldi S; Slimani N; Lenoir GM; Baglietto L; His M; Boutron-Ruault MC; Trichopoulou A; Lagiou P; Katsoulis M; Kaaks R; Kühn T; Panico S; Pala V; Masala G; Bueno-de-Mesquita HB; Peeters PH; van Gils C; Hjartåker A; Standahl Olsen K; Borgund Barnung R; Barricarte A; Redondo-Sanchez D; Menéndez V; Amiano P; Wennberg M; Key T; Khaw KT; Merritt MA; Riboli E; Gunter MJ; Romieu I
Ann Oncol; 2017 Nov; 28(11):2836-2842. PubMed ID: 28950350
[TBL] [Abstract][Full Text] [Related]
29. Thyroid Function and Cancer Risk: The Rotterdam Study.
Khan SR; Chaker L; Ruiter R; Aerts JG; Hofman A; Dehghan A; Franco OH; Stricker BH; Peeters RP
J Clin Endocrinol Metab; 2016 Dec; 101(12):5030-5036. PubMed ID: 27648963
[TBL] [Abstract][Full Text] [Related]
30. Correlation between tumor infiltrating immune cells and peripheral regulatory T cell determined using methylation analyses and its prognostic significance in resected gastric cancer.
Suh KJ; Kim JW; Kim JE; Sung JH; Koh J; Kim KJ; Kim JW; Ahn SH; Park DJ; Kim HH; Lee HS; Lee KW
PLoS One; 2021; 16(6):e0252480. PubMed ID: 34086741
[TBL] [Abstract][Full Text] [Related]
31. Albumin, bilirubin, uric acid and cancer risk: results from a prospective population-based study.
Kühn T; Sookthai D; Graf ME; Schübel R; Freisling H; Johnson T; Katzke V; Kaaks R
Br J Cancer; 2017 Nov; 117(10):1572-1579. PubMed ID: 28898231
[TBL] [Abstract][Full Text] [Related]
32. Urinary 8-isoprostane levels and occurrence of lung, colorectal, prostate, breast and overall cancer: Results from a large, population-based cohort study with 14 years of follow-up.
Gào X; Brenner H; Holleczek B; Cuk K; Zhang Y; Anusruti A; Xuan Y; Xu Y; Schöttker B
Free Radic Biol Med; 2018 Aug; 123():20-26. PubMed ID: 29778463
[TBL] [Abstract][Full Text] [Related]
33. Circulating Immune Cell Composition and Cancer Risk: A Prospective Study Using Epigenetic Cell Count Measures.
Le Cornet C; Schildknecht K; Rossello Chornet A; Fortner RT; González Maldonado S; Katzke VA; Kühn T; Johnson T; Olek S; Kaaks R
Cancer Res; 2020 May; 80(9):1885-1892. PubMed ID: 32075798
[TBL] [Abstract][Full Text] [Related]
34. CD4 helper T cells, CD8 cytotoxic T cells, and FOXP3(+) regulatory T cells with respect to lethal prostate cancer.
Davidsson S; Ohlson AL; Andersson SO; Fall K; Meisner A; Fiorentino M; Andrén O; Rider JR
Mod Pathol; 2013 Mar; 26(3):448-55. PubMed ID: 23041830
[TBL] [Abstract][Full Text] [Related]
35. Calcium Intake and Risk of Colorectal Cancer According to Tumor-infiltrating T Cells.
Yang W; Liu L; Keum N; Qian ZR; Nowak JA; Hamada T; Song M; Cao Y; Nosho K; Smith-Warner SA; Zhang S; Masugi Y; Ng K; Kosumi K; Ma Y; Garrett WS; Wang M; Nan H; Giannakis M; Meyerhardt JA; Chan AT; Fuchs CS; Nishihara R; Wu K; Giovannucci EL; Ogino S; Zhang X
Cancer Prev Res (Phila); 2019 May; 12(5):283-294. PubMed ID: 30760501
[TBL] [Abstract][Full Text] [Related]
36. Pre-diagnostic derivatives of reactive oxygen metabolites and the occurrence of lung, colorectal, breast and prostate cancer: An individual participant data meta-analysis of two large population-based studies.
Gào X; Wilsgaard T; Jansen EH; Holleczek B; Zhang Y; Xuan Y; Anusruti A; Brenner H; Schöttker B
Int J Cancer; 2019 Jul; 145(1):49-57. PubMed ID: 30561010
[TBL] [Abstract][Full Text] [Related]
37. White blood cell DNA methylation and risk of breast cancer in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO).
Sturgeon SR; Pilsner JR; Arcaro KF; Ikuma K; Wu H; Kim SM; Chopra-Tandon N; Karpf AR; Ziegler RG; Schairer C; Balasubramanian R; Reckhow DA
Breast Cancer Res; 2017 Aug; 19(1):94. PubMed ID: 28821281
[TBL] [Abstract][Full Text] [Related]
38. Prediagnostic Immune Cell Profiles and Breast Cancer.
Kresovich JK; O'Brien KM; Xu Z; Weinberg CR; Sandler DP; Taylor JA
JAMA Netw Open; 2020 Jan; 3(1):e1919536. PubMed ID: 31951276
[TBL] [Abstract][Full Text] [Related]
39. Structural chromosomal aberrations as potential risk markers in incident cancer patients.
Vodenkova S; Polivkova Z; Musak L; Smerhovsky Z; Zoubkova H; Sytarova S; Kavcova E; Halasova E; Vodickova L; Jiraskova K; Svoboda M; Ambrus M; Hemminki K; Vodicka P
Mutagenesis; 2015 Jul; 30(4):557-63. PubMed ID: 25800034
[TBL] [Abstract][Full Text] [Related]
40. Immunosuppressive regulatory T cells are associated with aggressive breast cancer phenotypes: a potential therapeutic target.
Bohling SD; Allison KH
Mod Pathol; 2008 Dec; 21(12):1527-32. PubMed ID: 18820666
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
